Dolphin Medical Services Ltd (NSE: DOLPHMED), ISIN INE796B01013 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
DOLPHMED last traded at ₹7.48 (-4.96%), with a 52-week range of ₹1.98 to ₹9.57 (as of 30 Jul 2026).
Shareholding as of Mar 2025: promoters 26.44%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 47/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.